Robert Espina
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Sensory Systems top 10%
- Ion Channels and Receptors
Papers in
-
- Metabolomics and Mass Spectrometry Studies 5
-
- Pharmacogenetics and Drug Metabolism 5
- Inflammatory mediators and NSAID effects 3
- Co-authors
- Abdul Mutlib (14 shared papers)JoAnn Scatina (6 shared papers)Rasmy Talaat (5 shared papers)Liang‐Shang Gan (7 shared papers)Linning Yu (3 shared papers)John P. Shockcor (6 shared papers)Jianyao Wang (3 shared papers)Dennis J. Crouch (1 shared paper)
- Journals
- Chemical Research in Toxicology (10 papers)Drug Metabolism and Disposition (3 papers)Reaction Chemistry & Engineering (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Xenobiotica (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Robert Espina
18 papers receiving 496 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 169
- Sensory Systems 49
- Spectroscopy 96
- Biochemistry 31
- Pharmaceutical Science 22
Countries citing papers authored by Robert Espina
This map shows the geographic impact of Robert Espina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Espina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Espina more than expected).
Fields of papers citing papers by Robert Espina
This network shows the impact of papers produced by Robert Espina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Espina. The network helps show where Robert Espina may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Espina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 107 | |
| 2 | 2008 | 74 | |
| 3 | 2008 | 64 | |
| 4 | 2010 | 51 | |
| 5 | 2000 | 29 | |
| 6 | 2002 | 24 | |
| 7 | 2002 | 23 | |
| 8 | 2012 | 22 | |
| 9 | 2001 | 21 | |
| 10 | 2008 | 20 | |
| 11 | 2001 | 19 | |
| 12 | 2000 | 18 | |
| 13 | 2010 | 18 | |
| 14 | Formation of unusual glutamate conjugates of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC 423) and its analogs: the role of gamma-glutamyltranspeptidase in the biotransformation of benzylamines. | 2001 | 16 |
| 15 | 2010 | 7 | |
| 16 | 2007 | 5 | |
| 17 | 2023 | 3 | |
| 18 | 2016 | 2 |
About Robert Espina
Robert Espina is a scholar working on Molecular Biology, Pharmacology, Biochemistry, Organic Chemistry and Infectious Diseases, having authored 18 papers that have together received 523 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (5 papers), Pharmacogenetics and Drug Metabolism (5 papers), Amino Acid Enzymes and Metabolism (4 papers), Inflammatory mediators and NSAID effects (3 papers), Quinazolinone synthesis and applications (3 papers), HIV/AIDS drug development and treatment (3 papers), Sulfur Compounds in Biology (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (169 citations), Sensory Systems (49 citations), Spectroscopy (96 citations), Biochemistry (31 citations) and Pharmaceutical Science (22 citations). Robert Espina has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Abdul Mutlib, JoAnn Scatina, Rasmy Talaat, Liang‐Shang Gan, Linning Yu, John P. Shockcor, Jianyao Wang, Dennis J. Crouch, Garold S. Yost and Sarvesh C. Vashishtha. Their work appears in journals such as Chemical Research in Toxicology, Drug Metabolism and Disposition, Reaction Chemistry & Engineering, Journal of Pharmacology and Experimental Therapeutics and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.